Who owns ACTINIUM PHARMACEUTICALS INC?
- Ticker: ATNM
- CUSIP Number: 00507w206
Tip: Access positions for across all investors
Analyze quarterly positions in Actinium Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Actinium Pharmaceuticals stock
Who bought or sold ACTINIUM PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.4M | $1.9M | 3% | Dec 2025 |
|
| Millennium Management | 625k | $1000k | -6% | Sep 2025 |
|
| Acadian Asset Management | 606k | $823k | 24% | Dec 2025 |
|
| Renaissance Technologies | 391k | $532k | 35% | Dec 2025 |
|
| BlackRock | 367k | $499k | 1% | Dec 2025 |
|
| Geode Capital Management | 329k | $448k | 0% | Dec 2025 |
|
| Two Sigma Investments | 234k | $375k | 403% | Sep 2025 |
|
| Gagnon Securities | 202k | $275k | -11% | Dec 2025 |
|
| Two Sigma Advisers | 196k | $314k | 100% | Sep 2025 |
|
| Citadel Advisors | 152k | $243k | 61% | Sep 2025 |
|
| State Street Corporation | 126k | $172k | 0% | Dec 2025 |
|
| Jane Street | 123k | $167k | 32% | Dec 2025 |
|
| Gen-Wealth Partners | 107k | $146k | -2% | Dec 2025 |
|
| Susquehanna International | 96k | $130k | -22% | Dec 2025 |
|
| Goldman Sachs Group | 70k | $96k | 100% | Dec 2025 |
|
| Squarepoint Ops | 66k | $89k | 100% | Dec 2025 |
|
| Bailard | 58k | $79k | 100% | Dec 2025 |
|
| Northern Trust | 43k | $58k | 19% | Dec 2025 |
|
| Bridgeway Capital Management | 40k | $64k | 0% | Sep 2025 |
|
| Dimensional Fund Advisors | 35k | $48k | 0% | Dec 2025 |
|
| Vontobel Holding | 30k | $41k | 0% | Dec 2025 |
|
| Am Investment Strategies | 29k | $40k | 100% | Dec 2025 |
|
| XTX Topco | 26k | $35k | 30% | Dec 2025 |
|
| Callan Family Office | 24k | $32k | 0% | Dec 2025 |
|
| Mayport | 22k | $30k | 0% | Dec 2025 |
|
| FMR | 21k | $34k | -13% | Sep 2025 |
|
| Advisor Group Holdings | 20k | $28k | 183% | Dec 2025 |
|
| North Star Asset Management | 20k | $27k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 20k | $27k | 0% | Dec 2025 |
|
| Qube Research & Technologies | 19k | $26k | -27% | Dec 2025 |
|
| AQR Capital Management | 17k | $27k | -78% | Sep 2025 |
|
| Cetera Investment Advisers | 15k | $21k | 5% | Dec 2025 |
|
| Russell Investments | 13k | $18k | 0% | Dec 2025 |
|
| Hrt Financial | 13k | $17k | 100% | Dec 2025 |
|
| Two Sigma Securities | 13k | $18k | 100% | Dec 2025 |
|
| Nine Masts Capital | 13k | $18k | 100% | Dec 2025 |
|
| Intrepid Financial Planning Group | 11k | $14k | -16% | Dec 2025 |
|
| Point72 Asset Management | 10k | $14k | 100% | Dec 2025 |
|
| Point72 Asia | 10k | $17k | -51% | Sep 2025 |
|
| Savvy Advisors | 10k | $14k | 100% | Dec 2025 |
|
| Level Four Advisory Services | 10k | $14k | 0% | Dec 2025 |
|
| Royal Bank of Canada | 5.7k | $0 | 1% | Sep 2025 |
|
| Rockefeller Capital Management | 4.0k | $5.4k | -11% | Dec 2025 |
|
| Steward Partners Investment Advisory | 2.2k | $2.9k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 1.6k | $2.5k | 100% | Sep 2025 |
|
| Federated Investors | 1.4k | $1.9k | -27% | Dec 2025 |
|
| NISA Investment Advisors | 958.00 | $1.3k | 0% | Dec 2025 |
|
| National Bank Of Canada /fi/ | 855.00 | $1.2k | 0% | Dec 2025 |
|
| SRS Capital Advisors | 707.00 | $962.014900 | 1979% | Dec 2025 |
|
| CWM | 620.00 | $999.998000 | -56% | Dec 2025 |
|
| SBI Securities | 542.00 | $737.011600 | 0% | Dec 2025 |
|
| Jones Financial Companies, L.L | 351.00 | $477.009000 | 0% | Dec 2025 |
|
| Pittenger & Anderson | 341.00 | $463.998700 | 0% | Dec 2025 |
|
| Investors Research Corp | 300.00 | $408.000000 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 237.00 | $321.988200 | 0% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 107.00 | $146.001500 | 0% | Dec 2025 |
|
| UBS Group | 96.00 | $130.905600 | -99% | Dec 2025 |
|
| EverSource Wealth Advisors | 16.00 | $22.000000 | -81% | Dec 2025 |
|
| Barclays | 1.00 | $1.000000 | -75% | Dec 2025 |
|
| Cubist Systematic Strategies | 1.00 | $2.000000 | -100% | Sep 2025 |
|
Who sold out of Actinium Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Marshall Wace | Sep 2025 | 26k | $42k |
| Advisory Services Network | Sep 2025 | 2.5k | $3.9k |
| Tower Research Capital | Sep 2025 | 555.00 | $888.000000 |
| Group One Trading | Sep 2025 | 547.00 | $874.981200 |
| Groupe la Francaise | Sep 2025 | 316.00 | $435.985200 |
| True Wealth Design | Sep 2025 | 2.00 | $4.000000 |